Dupilumab efficacy in uncontrolled, moderate-to-serve allergic asthma in the phase 3 liberty asthma quest study
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
Elsevier
2018
|
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
Elsevier
2018
|